Dr. Anil Mishra, PhD is Professor of Medicine and Endowed Chair, Edward G. Schlieder Educational Foundationin the Section of Pulmonary Diseases at Tulane School of Medicine, New Orleans, LA. He is also the Director ofEosinophilic Disorder Center at Tulane School of Medicine, New Orleans, LA. Dr. Mishra had an outstanding background, beginning with his distinguished education at Rajasthan University, Jaipur, India where he graduated with Bachelor of Science. Having excelled in science education, he then undertook PhD training at Kanpur University, Kanpur, India. His PhD studies primarily focused on the physiological function of the caudal neurosecretory gland of fish. Soon after completing his graduate training Dr. Mishra did postdoctoral training in the prestigious Institute of Toxicology, Lucknow, India and further at GSF Institute of Inhalation at Munchen, Germany. Dr. Mishra’s greatest break occurred in 1993 when he got an opportunity to train himself in United States. Dr. Mishra completed his postdoctoral training at Northestern Universities college of Medicine, Rootstown, OH, Tunale Universtity School of Medicien, New Orleans, LA and afterwards as a research associate at Indian University Purdu Institute of Medical College, Indianapolis, IN and Cincinnati Childrens Hospital Medical Center, Cincinnati, OH. Further, he served as a faculty member at Allergy and Immunology Division, Cincinnati Childrens Hospital Medical Center, Cincinnati, OH and Case Western Reserve University Medical College, OH before joining the Endowed Chair and Professor of Medicine at Tulane University School of Medicine, New Orleans, LA.Dr. Mishra’s most important contribution was to establish that eosinophils are the resident cell that home prenatally in the gastrointestinal tract (Mishra et al. J. Clin. Invest. 1999, 103, 1719-27) and the gastrointestinal tract (esophagus to colon) constitutively expresses eotaxin (an eosinophil selective chemoattractant). These finding indicated that the esophagus is devoid of resident eosinophils at baseline and eotaxin is not sufficient for eosinophil trafficking and homing into the tissues. Dr. Mishra developed a first murine model of asthma associated eosinophilic esophagitis (Mishra et al. J. Clin. Invest. 2001, 107, 83-90). These findings implicated aeroallergens in the etiology of EoE and suggested that esophageal eosinophilic inflammation is mechanistically associated with pulmonary inflammation (Mishra et al. J. Immunology 2002, 168, 2464-69 and Gastroenterology, 2003, 125. 1419-27). Dr. Mishra’s is an elected fellow of the American Academy of Allergy Asthma Immunology (FAAAAI), and American Gastrointestinal Association (FAGA). Dr. Mishra was the active member of Cincinnati Center for Eosinophilic Disorder (CCED) from the start of the center. He has over a 55 articles on molecular mechanisms of the pulmonary gastrintestinal toxicity and allergic responses. Some of his publications are cited more than 300 to 400 till 2013. Dr. Mishra’s research has been supported by the 2-differen intitutes of National Institutes of Health (NIDDK and NIAID) to understand the mechanism that induce EoE. He is serving in a number of study sections as member in NIH. More recently, his research implicated iNKT cells to the food and indoor insect allergens induce EoE and iNKT cell neutralization as a possible future therapy of EoE. He patents IL-15 responsive T cell associated molecules as a non-invasive biomarkers for EoE that differentiate EoE from GERD and rIL-15 treatment strategy for allergen-induced airway hyperactivity and lung or esophageal fibrosis.

Molecular Genetics
Tumor Biology & Signaling
Population Sciences & Prevention
Clinical and Translational Research
Cancer Health Disparities
Cancer Biology
Translational Research & Therapeutics
Prostate Cancer
Breast Cancer
Leukemia/Lymphoma
Gynecologic Cancers

Dr Ashutosh Chaturvedi has completed his graduation from Rajiv Gandhi University of health sciences, Bangalore, specialized in Panchakarma (Ayurveda Bio-purification) and received Post experience certificate in Diabetes Care from Glasgow, UK. He has standardised various experimental models for proving evidence for the use of the Bio purification methods over Diabetes. He is currently working as resident in Department of Panchakarma at SDM College of Ayurveda and Hospital, Hassan, India. He has published more than 26 articles in reputed journals, written book on "Ayurvedic Bio purification a remedy for Syndrome X" and received many best scientific paper in various international Conferences.

• Randomized Clinical Control Trail
• Model designing
• Experimental Pharmacology
• Pharmacognosy Research
• Biostatistics

Barabino Arrigo Vittorio, MD
Pediatrician involved in Pediatric Gastroenterology and Digestive Endoscopy from more than 20 years. Pediatric Gastroenterology training in London during 1990 (Great Ormond Street and Queen Elisabeth Hospitals). Consultant and Professor of Pediatric Gastroenterology at University of Genoa Italy. From 10 years Chief of Gastroenterology and Endoscopy Unit at G.Gaslini Institute for Children in Genoa. Member of Italian and European Societies of Pediatric Gastroenterology, Hepatology and Nutrition. Main interests: IBD, digestive endoscopy, chronic intestinal failure, intestinal motility disorders, clinical nutrition. Author of more than 100 papers published in scientific international journals. Member of the Editorial Board of Paediatric Care.

IBD, Digestive Endoscopy, Chronic intestinal failure, Intestinal motility disorders, Clinical nutrition.

Dr. EDITH OLAH
Professor of Molecular Genetics
Human geneticist and cancer researcher

PRESENT AND PREVIOUS POSITIONS
since 1986 First and current Head, Department of Molecular Genetics, National Institute of Oncology (NIO), Budapest, Hungary
1986-1992 Visiting Professor, Indiana University School Med (IUPUI), Indianapolis, IN, USA
1974-1985 Post-Doctoral Fellow/Senior Researcher, Institute of Oncopathology, NIO, Budapest

FIELDS OF RESEARCH/EXPERTISE:
Molecular cancer research with a focus on genetic predisposition to cancer and Clinical genetic testing of cancer susceptibility genes (breast-ovarian, colorectal and other cancers).

PUBLICATIONS: Author of 150 peer-reviewed papers on molecular cancer genetics.
6600 citations, H-index 42 (IF= 568)
https://vm.mtmt.hu//search/slist.php?lang=0&AuthorID=1169389

ADMINISTRATIVE FUNCTIONS IN RUNNING CANCER SOCIETIES and ORGANIZATIONS in last decade:
President, Eur Assoc Cancer Res (EACR)
Chair, Eur Coalition for Biomed Res
Coordinator, Central and Eastern Eur Cancer Genetics Network
Advisory Boards/Award Selection Committees (AACR, EACR, IARC, iPRI, EC)
President, Hungarian Cancer Society
EDITORIAL BOARD: member of 6 international journals (Molecular Oncology, Molecular Cancer Res)

HONOURS AND AWARDS:
2012 Fellow, Academia Europaea, London
2009 Fellow, European Academy of Cancer Sciences
2008 Honorary Member, European Association for Cancer Research (EACR)
2007 Member, Hungarian Academy of Sciences (Medical Division)

Molecular cancer research with a focus on genetic predisposition to cancer and Clinical genetic testing of cancer susceptibility genes (breast-ovarian, colorectal and other cancers).

Dr Madalina Ilie is an Assistant Professor of Gastroenterology in Clinical Emergency Bucharest. She received her M.D. from Carol Davila University. She has also received her Ph.D in medicine and master degree from Faculty of Biology, being very interested in Helicobacter pylori research, also being an author of a book about this thieme.

Her research interests are:
-interventional endoscopy: endoscopic submucosal dissection, EUS
-interventional ultrasound especially drainages
-Inflammatory Bowel Disease
-Colorectal Cancer research

Her research interests are:
- interventional endoscopy: endoscopic submucosal dissection, EUS
- interventional ultrasound especially drainages
- Inflammatory Bowel Disease
- Colorectal Cancer research

Dr. Mustafa Erboga, Ph.D and spesialist in Histology and Embryology and working at Department of Histology and Embryology, Namik Kemal University, Faculty of Medicine. He is a longstanding member of the International Federation of Societies of Microscopy, European Microscopy Society, International Federation of Societies for Histochemistry and Cytochemistry, Turkish Society for Electron Microscopy, and Turkish Society of Histology and Embryology. Fields of research prevalent: digestive system, gastroenterology, apoptosis, experimental studies, reproductive biology, and andrology. Author of more than 45 original papers, mainly on gastroenterology and reproductive biology. H-index: 13; number of citations: 353.

Fields of research prevalent: Digestive system, Gastroenterology, Apoptosis, Experimental studies, Reproductive biology, and Andrology.

Qu Bao-Ge, MSc is vice president and tertiary archiater of Taishan hospital of Shandong province. He is the Professor and master Tutor of Gerontology at Taishan Medicine College. He received his MSc from the University of Zhejiang Traditional Chinese Medicine in 2000. He received a BA in Clinical Medicine from Taishan Medicine College in 1987. He has received several funding of research support for clinical research since 2007. He is in the editorial board of the SM Journals and The Journal Diabetes Research and Metabolism: Open Access (DRMOA), and has been a grant reviewer for many clinical research. He is the author of over 100 articles. His research interests expand from the metabolism-related factors, inflammatory-immune markers and oxidative markers, alcohol consumption, acoholic fatty liver disease, other diseases, and carotid intima-media thickness.

His research interests expand from the metabolism-related factors, inflammatory-immune markers and oxidative markers, alcohol consumption, acoholic fatty liver disease, other diseases, and carotid intima-media thickness.

I am a Surgical Oncologist specialized in the diagnosis and treatment of malignant and benign injuries of liver, pancreas and colorectal liver metastases. I spent two years (2010 – 2012) as Research Fellow at Hepatopancreatobiliary Service of Memorial Sloan-Kettering Cancer Center (NY – USA) working on clinical research of surgical and systemic treatment of pancreatic cancer and colorectal liver metastases. Afterwards, I also spent one year as a resident of Hepatopancreatobiliary Service at Hospital Paul Brousse, France (2012/2013), dealing with liver and pancreas diseases, including colorectal liver metastases; liver and pancreas primary cancers; and patients in need of liver transplantation. I am an attending of the Liver Surgery Unit of University of São Paulo. I have been studying the effects of chemotherapy in patients with colorectal liver metastases and liver primary cancers, and looking for patient selection, surgical and long-term outcomes for patients who underwent curative-intent surgeries.

The effects of chemotherapy in patients with colorectal liver metastases and liver primary cancers, and looking for patient selection, surgical and long-term outcomes for patients who underwent curative-intent surgeries.

Dr. Renato Fasoli was born in Milan on November 24th 1959. He graduated in Medicine and specialised in Gastroenterology and Digestive Endoscopy at the University of Milan, Italy. He mastered in lower Gi Endoscopy at the Catholic University of Rome in 2007. He has been responsible of colorectal cancer screening programs in Trentino from 2007 to 2013 and in Western Liguria from 2013 on.
Besides screening organisation and diagnostic and therapeutic colonoscopy, his professional interests include nutrition, Ercp, upper Gi bleed and inflammatoy bowel disease. He recently partecipated to 3 multicentre studies on the management of malignant polyps (Fasoli, 2015), quality assurance (Zorzi et al. Gut 2014) and adenoma detection rate (Paggi et al. 2015) in screening colonoscopies.

Colorectal cancer screening programs, Colorectal interval cancers, Colorectal malignant polyps, Colonoscopy quality

Short Biography: Tao Li MD, pHD, Associate professor of Department of general surgery, Qilu Hospital, Shandong University. Research Interests:gastroenterology and hepatology

Gastroenterology and Hepatology

He had born at Diyarbakir city. He had graduated medical school at Diyarbakir University. Professor Vedat Goral is currently the Head of Department of Gastroenterology, at Izmir University School of Medicine. Previous to this, he was working at the Dicle University from 1987 to 2012. His specific teaching and research interests are in the areas of Gastroenterology (endoscopy, gastrointestinal diseases, liver diseases, inflammatory bowel diseases and ERCP). He has a international project about amoebiasis study at 1992-1993 years. He has also published many refereed articles in journals covered by SCI, and contributed some to Turkish books written in Turkish. Also, he has many abstracts at national and international congress.
He studied nearly 2 years (Monbusho Scholarship) at Department of Gastroenterology, Chiba University School of Medicine, Japan, 2 months at Department of Gastroenterology, Giessen University, Germany and at Department of Gastroenterology, Chelsea&Westminister Hospital, London University, England. He speaks English and Japanese languages.
Professor Goral completed his PhD degree Dicle University, Turkey in 1986; he has studied between 1990-1991 years at Chiba University, School of Medicine Department of Gastroenterology, Japan, and 1992 years Giessen University School of Medicine Department of Gastroenterology, Germany and at 1986 years Chealsea&Westminster Hospital, Department of Gastroenterology, England.

H. pylori, GI cancers, pancreatic cancer, endoscopy, ERCP, liver diseases.

Dr. Zheng received his Ph.D. degree in Biological Chemistry and Molecular Pharmacology from Harvard University in 1993, and postdoctoral training at Howard Hughes Medical Institute and the Department of Chemistry and Chemical Biology at Harvard University. He is a pioneer in mTOR signaling and an expert in nutrient signaling, and cancer growth, metabolism and targeted therapy, especially malignancies in the digestive system. He has been on faculty of Washington University and Rutgers University. He is currently Professor of Pharmacology, Chief of Division of Cancer Pharmacology, and Co-Leader of Program in Cancer Pharmacology of NCI-designated Comprehensive Cancer Centerat Rutgers University. Dr. Zheng has extensively published in leading peer-reviewed scientific journals including Nature, Cell, Cancer Cell, Molecular Cell, PNAS, EMBO, CurrBiol, and Nature Communications. Dr. Zheng’s research has been continuously funded by National Institutes of Health for the past 18 years.

Nutrient signaling; regulation of cell growth and metabolism; cancer (especially digestive track malignancies such as colorectal and liver cancers); targeted cancer therapy.

Dr. Xiaoshen Zhang, M.D.
TongjiUniversity ,China.
Radiation Oncology, Massachusetts General HospitalandHarvard Medical School, MA 02114, USA.
Xiaoshen Zhang is an associate researcher in the Tongji University Cancer Institute. He also performed as anassociate scholarinHarvard Medical School and Massachusetts General Hospital.
His main interest is the biology treatment of breast cancer and new anti-cancer medication design. He is now focusing on the stem cell treatment for breast cancer, and various translational medicine methods.His current projects concentrate on (1) Her2 positive breast cancer neo-treatment; (2) the microenvironment for cancer formation and cancer immunology; (3) stem cell induction treatment in early stage breast cancer.

His main interest is the biology treatment of breast cancer and new anti-cancer medication design. He is now focusing on the stem cell treatment for breast cancer, and various translational medicine methods. His current projects concentrate on

(1) Her2 positive breast cancer neo-treatment;
(2) The microenvironment for cancer formation and cancer immunology;
(3) stem cell induction treatment in early stage breast cancer.

Dr. Xingmin Sun, is an Assistant Professor in the Department of Molecular Medicine at the University of South Florida, USA. He received his M.S. in Microbiology & Immunology from Nanjing Agricultural University, China in 1994, his Ph.D. (magna cum laude) in Natural Sciences from University of Kiel, Germany in 2002, and did his postdoctoral training in Molecular Microbiology, Cell Biology & Biochemistry at Brown University, USA. He received Young Scientist Award from Federation of European Microbiological Societies in 2002, and Infectious Diseases Fellows Grant from American Society for Microbiology and the Infectious Diseases Society of America in 2008. His research is focused on the pathogenesis of Clostridium difficile and development of novel approaches to prevent/treat C. difficile infection (CDI). He is also interested in the role of intestinal microbiome in the pathogenesis of CDI. His lab is supported by NIH. He serves as Ad hoc reviewer for Infection and Immunity, Applied and Environmental Microbiology, Journal of Bacteriology, Journal of Clinical Microbiology, and Antimicrobial Agents and Chemotherapy.

His research is focused on the pathogenesis of Clostridium difficile and development of novel approaches to prevent/treat C. difficile infection (CDI). He is also interested in the role of intestinal microbiome in the pathogenesis of CDI.

Dr. Xuchun Zhou, female, M.D, Ph.D., associate professor

Education:
B.A.1989 Chongqing university of medical science, China
master's degree in internal medicine, 1995 Chongqing university of medical science, China
Ph.D. Department of digestion,2003 Chongqing university of medical science, China

Work experience:
She is engaged in digestive department for more than 20 years. She is good at dealing with the esophagus, stomach, liver, pancreas and intestinal diseases. She has published more than 30 professional papers. Research Interests: Basic or clinical research of irritable Bowel Syndrome (IBS)and inflammatory bowel disease(IBD)

Basic or clinical research of irritable Bowel Syndrome (IBS)and inflammatory bowel disease(IBD).

My name is Yingqun Zhou, and I am an associate chief physician from department of Gastroenterology, Tenth People's Hospital, Tongji University, P. R. China. I am the colleague of Dr. Chuanyong Guo. I will be interested in participating in the Editorial Committee and contributing to the journal.
I am very interested in the liver immunity and fibrosis area and have relevant knowledge and research experience.

Basic and clinical of gastroenterology diseases, including liver development, failure, and regeneration.
Signaling pathways in hepatocellular carcinoma and liver disease, such as RIP, TGF-ß and Hedgehog signaling pathway, autophagy.

This section will be updated soon..!

Gastrointestinal Malignancies
Gastroenterology
Hepatology
Neurogastroenterology
Gastrointestinal Disorders
Chronic Diarrhea
Galactosemia